Company · CIK 1878313
MAIA Biotechnology, Inc.
| CIK | 1878313 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | IL |
| Listed | MAIA (NYSE) |
| First annual or quarterly report | 2022-08-22 |
Offerings
6 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-299148 | 2026-09-25 | 2026-10-06 | 2 | |
| 333-298486 | 2026-08-21 | 2026-08-28 | 2 | |
| 333-273984 | 2023-08-15 | 2026-05-14 | 13 | |
| 333-272524 | 2023-06-08 | 2023-07-18 | 2 | |
| 333-269606 | 2023-02-06 | 2023-04-26 | 6 | |
| 333-264225 | 2022-04-11 | 2022-07-29 | 9 |
Filings
37| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-10-06 | EFFECTDeclared effective | 333-299148 | 9999999995-26-003161 |
| 2026-09-25 | S-3Shelf registered | 333-299148 | 0001493152-26-044361 |
| 2026-08-28 | EFFECTDeclared effective | 333-298486 | 9999999995-26-002814 |
| 2026-08-21 | S-3Shelf registered | 333-298486 | 0001493152-26-039679 |
| 2026-05-14 | 424B5Shelf takedown | 333-273984 | 0001493152-26-023160 |
| 2026-03-04 | 424B5Shelf takedown | 333-273984 | 0001493152-26-008784 |
| 2026-03-02 | 424B5Shelf takedown | 333-273984 | 0001493152-26-008571 |
| 2025-03-26 | 424B5Shelf takedown | 333-273984 | 0001641172-25-000776 |
| 2024-12-23 | 424B5Shelf takedown | 333-273984 | 0001193125-24-284258 |
| 2024-05-15 | 424B5Shelf takedown | 333-273984 | 0001193125-24-139359 |
| 2024-03-25 | 424B5Shelf takedown | 333-273984 | 0001193125-24-076472 |
| 2024-02-14 | 424B5Shelf takedown | 333-273984 | 0001193125-24-036598 |
| 2023-11-17 | 424B5Shelf takedown | 333-273984 | 0001193125-23-279377 |
| 2023-11-15 | 424B5Shelf takedown | 333-273984 | 0001193125-23-277563 |
| 2023-09-01 | 424B5Shelf takedown | 333-273984 | 0001193125-23-227681 |
| 2023-08-23 | EFFECTDeclared effective | 333-273984 | 9999999995-23-002485 |
| 2023-08-15 | S-3Shelf registered | 333-273984 | 0001193125-23-212576 |
| 2023-07-18 | RWWithdrawn | 333-272524 | 0001193125-23-188530 |
| 2023-06-08 | S-1Registration filed | 333-272524 | 0001193125-23-163582 |
| 2023-06-01 | DRSDraft made public | 377-06733 | 0000950123-23-005623 |
| 2023-04-26 | 424B4Final prospectus | 333-269606 | 0001564590-23-006228 |
| 2023-04-24 | EFFECTDeclared effective | 333-269606 | 9999999995-23-001027 |
| 2023-04-21 | S-1/AAmendment | 333-269606 | 0001564590-23-006057 |
| 2023-04-20 | S-1/AAmendment | 333-269606 | 0001564590-23-005968 |
| 2023-04-04 | S-1/AAmendment | 333-269606 | 0001564590-23-005432 |
| 2023-02-06 | S-1Registration filed | 333-269606 | 0001564590-23-001518 |
| 2022-12-23 | DRSDraft made public | 377-06525 | 0000950123-22-012719 |
| 2022-07-29 | 424B4Final prospectus | 333-264225 | 0001564590-22-027005 |
| 2022-07-27 | EFFECTDeclared effective | 333-264225 | 9999999995-22-002172 |
| 2022-07-21 | S-1/AAmendment | 333-264225 | 0001564590-22-026067 |
| 2022-07-13 | S-1/AAmendment | 333-264225 | 0001564590-22-025709 |
| 2022-06-29 | S-1/AAmendment | 333-264225 | 0001564590-22-024583 |
| 2022-05-31 | S-1/AAmendment | 333-264225 | 0001564590-22-021928 |
| 2022-05-16 | S-1/AAmendment | 333-264225 | 0001564590-22-020206 |
| 2022-04-29 | S-1/AAmendment | 333-264225 | 0001564590-22-016863 |
| 2022-04-11 | S-1Registration filed | 333-264225 | 0001564590-22-014036 |
| 2021-10-15 | DRSDraft made public | 377-05598 | 0000950123-21-013209 |